Inventor · disambiguated record
Su Youn Nam
Also filed as: NAM SU YOUN
10 granted patents·7 pending applications·13 citations·filing 2013–2024
81Inventor score
Top patents by PatentIndex Score
17 records- 0192US11857601B2Pharmaceutical composition for cancer treatment comprising fusion protein including IL-2 protein and CD80 protein and anticancer drugGI INNOVATION INC·Filed 2021·Granted Jan 2, 2024·3 cites·11 claims
- 0291US11639383B2Pharmaceutical composition for treatment of cancer, comprising an immune checkpoint inhibitor antibody and a fusion protein comprising an IL-2 mutant and a CD80 extracellular domainGI INNOVATION INC·Filed 2020·Granted May 2, 2023·3 cites·5 claims
- 0391US11136364B2Dual function proteins comprising FGF21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2016·Granted Oct 5, 2021·6 cites·25 claims
- 0486US12478675B2Pharmaceutical composition for enhancing radiotherapy comprising fusion protein containing IL-2 protein and CD80 proteinGI INNOVATION INC·Filed 2021·Granted Nov 25, 2025·1 cites·26 claims
- 0579US2025270269A1Dual function proteins comprising fgf21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2024·Application pending·0 cites
- 0676US2024279296A1Long-acting fgf21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2023·Application pending·0 cites
- 0768US2022002367A1Long-acting fgf21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2021·Application pending·0 cites
- 0868US2023257459A1Pharmaceutical composition for treatment of cancer, comprising an immune checkpoint inhibitor antibody and a fusion protein comprising an il-2 mutant and a cd80 extracellular domainGI INNOVATION INC·Filed 2023·Application pending·0 cites
- 0968US2022002368A1Dual function proteins comprising fgf21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2021·Application pending·0 cites
- 1064US2024058420A1Pharmaceutical composition for cancer treatment comprising fusion protein including il-2 protein and cd80 protein and anticancer drugGI INNOVATION INC·Filed 2023·Application pending·0 cites
- 1162US11142557B2Long-acting FGF21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2016·Granted Oct 12, 2021·0 cites·17 claims
- 1250US2023279124A1Fusion protein comprising ige fc receptor alpha subunit extracellular domain and anti-il-4r antibody, and use thereofGI INNOVATION INC·Filed 2021·Application pending·0 cites
- 1348US11046742B2Fusion protein comprising CCL3 variant and use thereofYUHAN CORP·Filed 2017·Granted Jun 29, 2021·0 cites·8 claims
- 1444US10941136B2Quinazoline derivative or its salt and pharmaceutical composition comprising the sameYUHAN CORP·Filed 2017·Granted Mar 9, 2021·0 cites·13 claims
- 1544US10383859B2Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including sameYUHAN CORP·Filed 2017·Granted Aug 20, 2019·0 cites·8 claims
- 1640US9663495B2Triazolone derivatives or salts thereof and pharmaceutical composition comprising the sameYUHAN CORP·Filed 2014·Granted May 30, 2017·0 cites·13 claims
- 1738US9493478B2Fused ring compound containing furan or salt thereof and pharmaceutical composition comprising sameYUHAN CORP·Filed 2013·Granted Nov 15, 2016·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Su Youn Nam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →